Global IVD Infectious Diseases Market Growth (Status and Outlook) 2025-2031

According to this study, the global IVD Infectious Diseases market size will reach US$ 23460 million by 2031.

In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.

United States market for IVD Infectious Diseases is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for IVD Infectious Diseases is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for IVD Infectious Diseases is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key IVD Infectious Diseases players cover BD, BioMerieux, Abbott, Quidel, Gen-Probe, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “IVD Infectious Diseases Industry Forecast” looks at past sales and reviews total world IVD Infectious Diseases sales in 2024, providing a comprehensive analysis by region and market sector of projected IVD Infectious Diseases sales for 2025 through 2031. With IVD Infectious Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IVD Infectious Diseases industry.

This Insight Report provides a comprehensive analysis of the global IVD Infectious Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on IVD Infectious Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IVD Infectious Diseases market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IVD Infectious Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IVD Infectious Diseases.

This report presents a comprehensive overview, market shares, and growth opportunities of IVD Infectious Diseases market by product type, application, key players and key regions and countries.

Segmentation by Type:
Immunochemistry
Molecular Diagnostics

Segmentation by Application:
Clinical Laboratories
Diagnostic Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
BioMerieux
Abbott
Quidel
Gen-Probe
Abbott
Danaher
Sysmex
Orasure
Hologic
Cepheid
Qiagen
Roche Diagnostics
Siemens Healthcare
Bio-Rad Laboratories

Please note: The report will take approximately 2 business days to prepare and deliver. Show more